Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Anaxagoras who wrote (1306)	4/9/1999 3:24:00 PM
From: tuck	Respond to of 1432

Apparently, Abbot's vaguely conservative estimates of market size disappointed BTIM, too: go2net.newsalert.com $400 million is near the top end of what I've heard, and the stock is responding. Who's right? Time will tell. I'd have to do some DD to find out why Gensia has had such poor performance in marketing a similar product. Perhaps they had tried to beat big pharma with a product that sounds little different from what big pharma was itself selling, instead of joining them as BTIM has with a product that has some differentiation? If anyone knows the story, I am curious. Else I'll try to run it down myself next week. Cheers, Tuck